Rhythm Biosciences Ltd ('RHY', the 'Company' or the 'Group') (ASX: RHY), a transformative, predictive cancer diagnostics ...

Saga Diagnostics expanded the use of its ultrasensitive blood test to include detection of tiny amounts of colorectal cancer ...

For 10% of colorectal cancer patients, hereditary factors play a role, with higher percentages among younger patients.

New global initiative urges patients and clinicians to wait for biomarker testing results before starting treatment.

Colon cancer treatment is personalized based on stage, overall health and tumor characteristics. Early detection and accurate ...

Rhythm Biosciences has materially improved the predictive accuracy of its geneType colorectal cancer risk assessment clinical ...

It’s good news in the fight against colorectal cancer: A new test can detect the disease with a simple blood draw. But don’t cancel your colonoscopy just yet — that old standby is still more reliable ...

Fecal occult blood testing, a patient-administered test that is much less expensive than a colonoscopy, is a valid option for early detection of colon cancer, according to a report in the Canadian ...

According to Cologuard, made by Wisconsin-based Exact Sciences, there are three primary reasons why you may receive a testing ...

Dr. Bethany Malone has treated a lot of colorectal cancer patients. The youngest, not counting those with genetic conditions, ...

According to a 2025 survey conducted by the Prevent Cancer Foundation, only 51% of U.S. adults 21 and older say they have had ...